Compare ARMP & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARMP | OPRT |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 263.0M |
| IPO Year | 1996 | 2019 |
| Metric | ARMP | OPRT |
|---|---|---|
| Price | $5.45 | $5.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $15.00 | $7.00 |
| AVG Volume (30 Days) | 189.6K | ★ 497.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 127.18 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $956,685,000.00 |
| Revenue This Year | N/A | $32.79 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $118.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.14 | $4.03 |
| 52 Week High | $14.98 | $7.33 |
| Indicator | ARMP | OPRT |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 67.94 |
| Support Level | $5.14 | $5.06 |
| Resistance Level | $7.67 | $6.19 |
| Average True Range (ATR) | 0.71 | 0.25 |
| MACD | -0.09 | 0.08 |
| Stochastic Oscillator | 1.57 | 84.51 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.